STOCK TITAN

DNA X SEC Filings

SONM NASDAQ

Welcome to our dedicated page for DNA X SEC filings (Ticker: SONM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

DNA X, Inc. filings document the company's shift from Sonim Technologies to a cryptocurrency trading-services business, including the acquisition of DNA X LLC, the completed sale of mobile device assets, and the January 2026 corporate rebrand while the Nasdaq ticker remained SONM.

The filing record includes Current Reports on Form 8-K and related amendments covering material agreements, convertible-note financing, common-stock issuance, operating results, shareholder voting matters, executive departures and compensation arrangements, and auditor changes. Other disclosures address late annual-report notification, internal-control weakness, going-concern language, capital structure, risk factors, and financial-reporting obligations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Orbic North America has submitted a significant asset purchase proposal to Sonim Technologies, offering to acquire substantially all assets for $25 million cash ($2.418 per share). The proposal comes with a $50 million financing commitment from a third-party lender.

Key aspects of the filing:

  • Orbic and AJP Holding Company jointly own approximately 19% of Sonim's outstanding common stock
  • The offer allows Sonim to simultaneously pursue the previously announced Reverse Take-Over transaction
  • Orbic is prepared for expedited due diligence and negotiation of a definitive agreement

The filing also reveals that AJP/Orbic Parties are soliciting proxies for the 2025 Annual Meeting, with five director nominees: Douglas Benedict, Joseph Glynn, Gregory Johnson, Suren Singh, and Michael Wallace. This DFAN14A filing indicates an active attempt to influence Sonim's corporate governance while pursuing the acquisition.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Sonim Technologies (NASDAQ:SONM) announced signing a non-binding letter of intent for a potential business combination with a private company operating in high-performance computing and AI infrastructure. The company is pursuing a dual-track strategy involving: (1) a business combination with the target company and (2) the previously disclosed sale of substantially all of Sonim's operating assets.

The transaction would require approval from both companies' boards and stockholders, along with other customary closing conditions. The company has filed additional proxy materials related to its 2025 Annual Meeting of Stockholders and will file a separate proxy statement for the special meeting regarding the proposed transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.5%
Tags
proxy
Rhea-AI Summary

Sonim Technologies (NASDAQ:SONM) announced significant developments in its strategic alternatives process through an 8-K filing. The company has entered into a non-binding letter of intent for a potential business combination with a private company operating in high-performance computing and AI data processing infrastructure.

The company is pursuing a dual-track strategy: (1) a business combination with the target company and (2) the sale of substantially all of Sonim's operating assets. Both transactions require definitive agreements and are subject to board and stockholder approvals. The company has also filed proxy materials for its 2025 Annual Meeting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.5%
Tags
current report
-
Rhea-AI Summary

AJP Holding Company and associated parties have filed Amendment No. 11 to their Schedule 13D regarding Sonim Technologies (SONM), disclosing significant ownership changes and proxy contest developments. Key points include:

The reporting group collectively owns 1,947,345 shares representing 19.04% of Sonim's outstanding common stock. The ownership structure includes:

  • AJP Holding Company LLC: 1,946,345 shares shared dispositive power
  • Jeffrey Wang: 25,779 direct shares plus shared interest in AJP holdings
  • Orbic North America LLC: 1,000 shares shared dispositive power
  • Ashima Narula and Parveen Narula: Shared voting power over 1,947,345 shares

On June 24, 2025, AJP and Orbic filed Definitive Preliminary Proxy Materials and issued a press release announcing their nomination of five board candidates for election at Sonim's Annual Meeting scheduled for July 18, 2025. This indicates an active push for board representation and potential influence over company direction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
Rhea-AI Summary

Sonim Technologies, Inc. (Nasdaq: SONM) filed a Form S-1 on 20 June 2025 to register a best-efforts equity offering that could raise new capital through a mix of common stock and warrants. The preliminary prospectus covers up to 6,896,551 shares of common stock, an equal number of pre-funded warrants (exchangeable 1-for-1 at a token $0.001 exercise price) for investors seeking to cap post-offering ownership at 4.99 % (optionally 9.99 % after 61 days), and placement-agent warrants for up to 206,897 additional shares. A further 7,103,448 shares are being registered for issuance upon warrant exercise, bringing total potential new shares to roughly 14 million.

The deal, led by Roth Capital Partners, carries a 7 % cash fee plus 3 % warrant coverage for the placement agent. Pricing will be fixed for the life of the offering but may be set at a discount to the last quoted share price of $1.45 (18 June 2025). No escrow account and no minimum raise are required; the company may close with any dollar amount (or none) before the self-selected termination date of 31 July 2025.

Sonim is classified as a non-accelerated filer and smaller reporting company, allowing scaled disclosure. The filing highlights that investing in the securities "involves a high degree of risk," directing readers to Risk Factors beginning on page 9. There is no established market for the pre-funded warrants, and none is expected to develop.

Key administrative information includes: Delaware incorporation; SIC 3661 (communications equipment); principal offices at 4445 Eastgate Mall, Suite 200, San Diego, CA 92121; and CEO Peter Liu listed as agent for service. The S-1 will remain preliminary until declared effective by the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Summary

Sonim Technologies (ticker: SONM) has filed a DEFA14A to supplement its proxy materials for the upcoming July 18, 2025 Annual Meeting of Stockholders. The Board is engaged in an ongoing review of strategic alternatives and highlights an effort by Orbic North America, LLC to gain control of the company. In response, Sonim’s directors unanimously recommend that shareholders vote FOR all board-nominated directors by submitting the WHITE proxy card as soon as possible. The filing details where investors can obtain the definitive proxy statement, identifies directors and officers who may be deemed solicitation participants, and provides proxy-solicitor contact information—toll-free (800) 662-5200 or SONM@investor.sodali.com—for voting assistance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Sonim Technologies, Inc. (NASDAQ: SONM) has filed Definitive Additional Proxy Materials (DEFA14A) ahead of its 18 July 2025 Annual Meeting. The filing focuses on the company’s six-month strategic alternatives review triggered by an unsolicited bid from Orbic North America, LLC. A Special Committee, supported by external advisers, evaluated multiple options and now claims to have identified a superior two-step transaction set.

  • Asset sale to Social Mobile: A non-binding Letter of Intent signed 2 June 2025 contemplates the sale of “substantially all” operating assets for up to $20 million, including a potential $5 million earn-out.
  • Reverse takeover (RTO): Sonim is negotiating a reverse merger with a private operating company that would assign Sonim an estimated $15 million valuation. Combined, the two transactions could exceed the implied value of Orbic’s cash offers.

Critique of Orbic’s proposals. The committee characterises Orbic’s campaign as coercive, highlighting:

  • Three successive non-binding offers ($4.00 per share in February, reduced to $1.81 per share in May) lacking verifiable financing.
  • Refusal to provide proof of funds and alleged threats to Sonim’s supply chain.
  • Legal and financial instability: >10 lawsuits in the past decade and $22.5 million in judgments against Orbic and affiliates.

Board recommendation. The Board urges shareholders to use the WHITE proxy card to re-elect incumbent nominees—James Cassano, Peter Liu, Mike Mulica, Jack Steenstra and George Thangadurai—and to disregard Orbic’s BLUE card. The company emphasises the nominees’ independence and alignment with all shareholders.

Key dates & logistics. • Record date: not disclosed in this excerpt. • Annual Meeting: 18 July 2025. • Proxy solicitor: Sodali LLC (toll-free +1 800 662-5200).

Investor takeaway: Sonim asserts that the Social Mobile LOI plus a potential RTO deliver higher aggregate value and certainty than Orbic’s conditional bids, while maintaining that Orbic’s proxy fight seeks control without a premium. Shareholders must weigh an asset-sale/RTO path that effectively monetises core operations against retaining full-operating control under a contested takeover scenario.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.41%
Tags
proxy

FAQ

How many DNA X (SONM) SEC filings are available on StockTitan?

StockTitan tracks 80 SEC filings for DNA X (SONM), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for DNA X (SONM)?

The most recent SEC filing for DNA X (SONM) was filed on June 26, 2025.